A spinoff company, Athira Pharma (formalized as M3 Biotechnology before rebranding), was founded in 2011 by PhD student Leen Kawas to commercialize dihexa and a related molecule, ATH-1017 (fosgonimeton)
To better meet the needs of our customers, we offer personalized shipping plans that work with production needs
Trimming Away Stubborn Belly Fat That frustrating belly fat that seems impossible to lose
4 Plus, in rat models of colocutaneous, gastrocutaneous, and rectovaginal fistulas, BPC-157 successfully closed the skin defect and the internal organ defect
Stem cell mobilization: Research suggests TB-500 promotes the migration of stem and progenitor cells to injury sites, accelerating tissue rebuilding from the cellular level
Dihexa for Baby Brain & Postpartum Brain Fog Why baby brain is real: the Davies 2018 Medical Journal of Australia meta-analysis, the Hoekzema 2017 and Pritschet 2024 Nature Neuroscience maternal-brain remodelling studies, the postpartum estradiol-BDNF crash, the allopregnanolone / brexanolone / zuranolone (Zurzuvae, FDA Aug 2023) neurosteroid story, the dominant sleep, postpartum-thyroiditis and iron drivers, ONS 567,708 England births (2024) and the RCPsych July 2025 postnatal-depression estimate and why pregnancy and breastfeeding are absolute contraindications for an unlicensed HGF/c-Met peptide